Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1
Carlos G. Romo(Johns Hopkins University), Jaishri O. Blakeley(Johns Hopkins University), Anna F. Piotrowski(Memorial Sloan Kettering Cancer Center), Tejus Bale(Memorial Sloan Kettering Cancer Center), Ingo K. Mellinghoff(Memorial Sloan Kettering Cancer Center), Jose Diarte(Memorial Sloan Kettering Cancer Center), Jian Campian, Laura Prichett(Johns Hopkins University), David H. Gutmann(Washington University in St. Louis), Sonika Dahiya(Washington University in St. Louis), Fausto J. Rodríguez(University of California, Los Angeles), Calixto‐Hope G. Lucas(Johns Hopkins University)
Cited by 33
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
Glioblastoma and Other Primary Brain Malignancies in Adults
|JAMA|2023|1.1k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma
|Proceedings of the National Academy of Sciences|2007|1.1k